Hans‐Georg Capraro

In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

Carlos Garcı́a-Echeverrı́a, Mark Pearson, Andreas Marti et al. · Cancer Cell · 2004 · 535 citations · Full text

Cancer Research, Medicine, Receptor Tyrosine Kinase +9

New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors:  Candidates for Clinical Development

Guido Bold, Alexander Fässler, Hans‐Georg Capraro et al. · Journal of Medicinal Chemistry · 1998 · 199 citations · Full text

Immunology, Pharmacotherapy, Antiviral Drug +17

Biological effects of modified colchicines. Improved preparation of 2-demethylcolchicine, 3-demethylcolchicine, and (+)-colchicine and reassignment of the position of the double bond in dehydro-7-deacetamidocolchicines

M. ROESNER, Hans‐Georg Capraro, Arthur E. Jacobson et al. · Journal of Medicinal Chemistry · 1981 · 93 citations

2,6,9-trisubstituted purines : Optimization towards highly potent and selective CDK1 inhibitors

Patricia Imbach, Hans‐Georg Capraro, Pascal Furet et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 81 citations · Full text

Medicinal Chemistry, Selective Cdk1 Inhibitors, 2,6,9-Trisubstituted Purines +13

Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability

Alexander Fässler, Guido Bold, Hans‐Georg Capraro et al. · Journal of Medicinal Chemistry · 1996 · 78 citations · Full text

Oral Bioavailability, Bioorganic Chemistry, Immunology +19